Thiabendazole how supplied: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Thiabendazole}} {{CMG}} <ref>{{Cite web | last = | first = | title = http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/16096slr033,16097slr026_mintez...")
 
mNo edit summary
Line 3: Line 3:
{{CMG}}
{{CMG}}


==How Supplied==


No. 3331 — MINTEZOL Suspension, 500 mg per 5 mL, is white to off-white and is supplied as follows:


* NDC 0006-3331-60 in bottles of 120 mL (6505-00-935-5835, 0.5 g/5 mL, 120 mL).


<ref>{{Cite web  | last =  | first =  | title = http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/16096slr033,16097slr026_mintezol_lbl.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/16096slr033,16097slr026_mintezol_lbl.pdf | publisher =  | date =  | accessdate = }}</ref>
Storage
 
Store in a well-closed container at controlled room temperature [15-30°C (59-86°F)]. Protect from freezing.
 
No. 3332 — MINTEZOL Chewable Tablets, 500 mg, are white to off-white, orange-flavored, round, scored, compressed tablets, coded MSD 907 on one side and MINTEZOL on the other. They are supplied as follows:
 
* NDC 0006-0907-36 unit dose packages of 36 (6505-01-226-9909, 500 mg chewable, individually sealed 36's).
 
Storage
 
Store in a well-closed container at controlled room temperature [15-30°C (59-86°F)].<ref>{{Cite web  | last =  | first =  | title = http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/16096slr033,16097slr026_mintezol_lbl.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/16096slr033,16097slr026_mintezol_lbl.pdf | publisher =  | date =  | accessdate = }}</ref>


==References==
==References==

Revision as of 23:11, 6 January 2014

Thiabendazole
MINTEZOL® FDA Package Insert
Description
Clinical Pharmacology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

How Supplied

No. 3331 — MINTEZOL Suspension, 500 mg per 5 mL, is white to off-white and is supplied as follows:

  • NDC 0006-3331-60 in bottles of 120 mL (6505-00-935-5835, 0.5 g/5 mL, 120 mL).

Storage

Store in a well-closed container at controlled room temperature [15-30°C (59-86°F)]. Protect from freezing.

No. 3332 — MINTEZOL Chewable Tablets, 500 mg, are white to off-white, orange-flavored, round, scored, compressed tablets, coded MSD 907 on one side and MINTEZOL on the other. They are supplied as follows:

  • NDC 0006-0907-36 unit dose packages of 36 (6505-01-226-9909, 500 mg chewable, individually sealed 36's).

Storage

Store in a well-closed container at controlled room temperature [15-30°C (59-86°F)].[1]

References

  1. "http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/16096slr033,16097slr026_mintezol_lbl.pdf" (PDF). External link in |title= (help)

Adapted from the FDA Package Insert.